- Registration approval of NURTEC ODT in Kuwait is third in Middle East region, joining prior market approvals in Israel and United Arab Emirates - NURTEC ODT is the first and only calcitonin ...
NEW HAVEN, Conn., Jan. 6, 2022 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a biopharmaceutical company with a portfolio of innovative, late-stage product candidates, ...
- Insurance Coverage of Nurtec ODT Now Totals 96 Percent of Commercial Lives or Approximately 255 Million Lives Covered in All Channels - Nurtec ODT Label Expanded to include Lactation Data in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results